Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-036564

Dova Pharmaceuticals Inc. · DOVA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul B Manning
Director · 10% Owner
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 8:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001685071

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 6, 2018P17,000$28.85A12,477,823D
Common StockF3,F4Jun 7, 2018P6,600$27.52A12,484,423D
Common StockF5,F6Jun 7, 2018P3,400$28.03A12,487,823D
Common StockF7holding———1,783,226IBy LLC

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses